David Murphy

David Murphy

Auto-generated profile, based on publicly available information

David Murphy

Molecular Neuroendocrinology Research Group, Bristol Medical School: Translational Health Sciences, University of Bristol, Dorothy Hodgkin Building, Bristol, United Kingdom

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2001 in Physiological Reviews
Verified
Journal Article
Closed access
PDF file
JBJ. Peter H. Burbach
J. Peter H. Burbach
SLSimon M. Luckman
Simon M. Luckman
DMDavid Murphy
David Murphy
HGHarold Gainer
Harold Gainer
The hypothalamo-neurohypophysial system (HNS) is the major peptidergic neurosecretory system through which the brain controls peripheral physiology. The hormones vasopressin and oxytocin released from the HNS at the neurohypophysis serve homeostatic functions of water balance and reproduction. From a physiological viewpoint, the core question on the HNS has always been, “How is the rate of hormone production controlled?” Despite a clear description of the physiology, anatomy, cell biology, and biochemistry of the HNS gained over the last 100 years, this question has remained largely unanswered. However, recently, significant progress has been made through studies of gene identity and gene expression in the magnocellular neurons (MCNs) that constitute the HNS. These are keys to mechanisms and events that exist in the HNS. This review is an inventory of what we know about genes expressed in the HNS, about the regulation of their expression in response to physiological stimuli, and about their function. Genes relevant to the central question include receptors and signal transduction components that receive and process the message that the organism is in demand of a neurohypophysial hormone. The key players in gene regulatory events, the transcription factors, deserve special attention. They do not only control rates of hormone production at the level of the gene, but also determine the molecular make-up of the cell essential for appropriate development and physiological functioning. Finally, the HNS neurons are equipped with a machinery to produce and secrete hormones in a regulated manner. With the availability of several gene transfer approaches applicable to the HNS, it is anticipated that new insights will be obtained on how the HNS is able to respond to the physiological demands for its hormones.

1 December 1983 in Nature
Verified
Journal Article
Open access
PDF file
PBPaul M. Brickell
Paul M. Brickell
DLDavid S. Latchman
David S. Latchman
DMDavid Murphy
David Murphy
KWKeith Willison
Keith Willison
PRPeter W. J. Rigby
Peter W. J. Rigby
A cDNA clone corresponding to a mRNA present at elevated levels in transformed fibroblasts encodes a Qa / Tla class I major histocompatibility complex (MHC) antigen. High levels of this mRNA are found in all tumour cells tested; the transcript can undergo alternative splicing; and a repetitive sequence within the transcription unit has the characteristics of a transposable element. The immunological implications of MHC gene activation in tumour cells are discussed.

1 January 2005 in Endocrinology
Verified
Journal Article
Closed access
YUYoichi Ueta
Yoichi Ueta
HFHiroaki Fujihara
Hiroaki Fujihara
RSRyota Serino
Ryota Serino
Govindan DayanithiGovindan Dayanithi
Govindan Dayanithi
HOHitoshi Ozawa
Hitoshi Ozawa
DMDavid Murphy
David Murphy
We have generated transgenic rats expressing an arginine vasopressin (AVP)-enhanced green fluorescent protein (eGFP) fusion gene. The expression of the eGFP gene and strong fluorescence were observed in the supraoptic nucleus (SON), the paraventricular nucleus (PVN), and the suprachiasmatic nucleus (SCN) in transgenic rats. The hypothalamo-neurohypophyseal tract, isolated SON neurons, and isolated axon terminals in the neurohypophysis also showed robust eGFP fluorescence. Water deprivation for 2 d increased the fluorescence of the eGFP in the SON and the PVN but not the SCN. The whole-cell patch-clamp technique was then used to record the electrical activities specifically identifying eGFP-expressing SON, PVN, and SCN AVP neurons in in vitro brain slice preparations. The AVP-eGFP transgenic rats are a unique new tool with which to study the physiological role of AVP-secreting neurons in the central nervous system and the dynamics of the regulation of AVP secretion in the living neurons and their axon terminals.

1 March 2001 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
JPJulian F. R. Paton
Julian F. R. Paton
JDJim Deuchars
Jim Deuchars
ZAZai Ahmad
Zai Ahmad
LWL.‐F. Wong
L.‐F. Wong
DMDavid Murphy
David Murphy
SKSergey Kasparov
Sergey Kasparov
1 Angiotensin II (ANGII) acting on ANGII type 1 (AT1) receptors in the solitary tract nucleus (NTS) depresses the baroreflex. Since ANGII stimulates the release of nitric oxide (NO), we tested whether the ANGII‐mediated depression of the baroreflex in the NTS depended on NO release. 2 In a working heart‐brainstem preparation (WHBP) of rat NTS microinjection of either ANGII (500 fmol) or a NO donor (diethylamine nonoate, 500 pmol) both depressed baroreflex gain by ‐56 and ‐67 %, respectively (P < 0.01). In contrast, whilst ANGII potentiated the peripheral chemoreflex, the NO donor was without effect. 3 NTS microinjection of non‐selective NO synthase (NOS) inhibitors (l‐NAME; 50 pmol) or (l‐NMMA; 200 pmol) prevented the ANGII‐induced baroreflex attenuation (P > 0.1). In contrast, a neurone‐specific NOS inhibitor, TRIM (50 pmol), was without effect. 4 Using an adenoviral vector, a dominant negative mutant of endothelial NOS (TeNOS) was expressed bilaterally in the NTS. Expression of TeNOS affected neither baseline cardiovascular parameters nor baroreflex sensitivity. However, ANGII microinjected into the transfected region failed to affect the baroreflex. 5 Immunostaining revealed that eNOS‐positive neurones were more numerous than those labelled for AT1 receptors. Neurones double labelled for both AT1 receptors and eNOS comprised 23 ± 5.4 % of the eNOS‐positive cells and 57 ± 9.2 % of the AT1 receptor‐positive cells. Endothelial cells were also double labelled for eNOS and AT1 receptors. 6 We suggest that ANGII activates eNOS located in either neurones and/or endothelial cells to release NO, which acts selectively to depress the baroreflex.

1 December 1983 in Cell
Verified
Journal Article
Closed access
DMDavid Murphy
David Murphy
PBPaul M. Brickell
Paul M. Brickell
DLDavid S. Latchman
David S. Latchman
KWKeith Willison
Keith Willison
PRPeter W.J. Rigby
Peter W.J. Rigby

1 June 1994 in Nature Biotechnology
Verified
Journal Article
Closed access
PWPhilip A. Walker
Philip A. Walker
LLLouis E. -C. Leong
Louis E. -C. Leong
PNPatrick W. P. Ng
Patrick W. P. Ng
STShyh-Han Tan
Shyh-Han Tan
SWSarah Waller
Sarah Waller
APAlan G. Porter
Alan G. Porter